Device-Detected Atrial Fibrillation.

Stroke is a devastating complication of atrial fibrillation (AF) the odds of which can be reduced by use of oral anticoagulation based on the stroke risk score.1,2 Patients with asymptomatic clinical AF have a similar stroke risk as patients with symptomatic clinical AF.3 Thus far, electrocardiographic- (ECG) or Holter monitor-detected AF is a prerequisite before use of oral anticoagulation,1,2 because the guideline recommendations are based on studies that included only ECG- or Holter-detected AF ('clinical' AF).1,2 In the past decades increasing number of cardiac implantable electronic devices (CIED) have been implanted in patients with cardiovascular diseases, predominantly driven by expanding indications for implantable cardioverter defibrillators (ICD), cardiac resynchronization therapy, and implantable loop recorders. These CIEDs can detect atrial high rate episodes i.e. atrial arrhythmias.4-6 As a consequence of continuous monitoring by these devices, the detection threshold for atrial tachyarrhythmias or AF has decreased dramatically. However, AF-detection algorithms, sensitivity, and specificity vary between CIEDs, and this may have its impact on the usage for AF detection purposes.7.

[1]  P. Kirchhof,et al.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, European heart journal.

[2]  Panos Vardas,et al.  Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non–vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH–AFNET 6) trial , 2017, American heart journal.

[3]  Martha J. Radford,et al.  Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation , 2001 .

[4]  Joel Stein,et al.  Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. , 2014, Circulation.

[5]  Mintu P Turakhia,et al.  Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation. , 2019, Circulation.

[6]  Giuseppe Boriani,et al.  Detection of new atrial fibrillation in patients with cardiac implanted electronic devices and factors associated with transition to higher device-detected atrial fibrillation burden. , 2017, Heart rhythm.

[7]  Marco Proietti,et al.  Asymptomatic versus symptomatic atrial fibrillation: A systematic review of age/gender differences and cardiovascular outcomes. , 2015, International journal of cardiology.

[8]  A. Capucci,et al.  Subclinical atrial fibrillation and the risk of stroke. , 2012, The New England journal of medicine.

[9]  Dongfeng Qi,et al.  The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk: The TRENDS Study , 2009, Circulation. Arrhythmia and electrophysiology.

[10]  Philippe Mabo,et al.  Rationale and design of the Apixaban for the Reduction of Thrombo‐Embolism in Patients With Device‐Detected Sub‐Clinical Atrial Fibrillation (ARTESiA) trial , 2017, American heart journal.

[11]  U. Schotten,et al.  Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation , 2017, European heart journal.

[12]  Hugh Calkins,et al.  Correction to: 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2019, Circulation.

[13]  G. Breithardt,et al.  Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[14]  Kenneth A Ellenbogen,et al.  Device-detected atrial fibrillation: what to do with asymptomatic patients? , 2015, Journal of the American College of Cardiology.